They usually test for pancreatic cancer using a mix of blood tests, imaging scans, and a biopsy, often done step by step rather than with a single “pancreatic cancer test.”

First steps: symptoms and basic tests

Doctors start by looking at symptoms (like jaundice, unexplained weight loss, or upper abdominal/back pain) and doing a physical exam, then ordering basic lab work.

These early tests can include blood tests to check liver function, bile duct blockage, and sometimes tumor markers such as CA 19‑9, which can support a diagnosis but cannot by itself confirm pancreatic cancer.

Imaging scans they use

To actually “see” the pancreas, doctors rely on detailed imaging:

  • Ultrasound of the abdomen to look for bile duct enlargement or obvious masses.
  • CT scan (often a special pancreatic protocol CT) to show the pancreas, nearby vessels, and whether anything looks like a tumor or has spread.
  • MRI and sometimes MRCP (MR cholangiopancreatography) for more detailed views of the pancreas and bile ducts when CT is inconclusive or more detail is needed.

Endoscopic tests (from the inside)

If scans look suspicious or more detail is needed, specialists often use endoscopic procedures:

  • Endoscopic ultrasound (EUS): A thin scope with an ultrasound probe goes down the throat into the stomach/duodenum to get very close images of the pancreas and nearby lymph nodes.
  • ERCP (endoscopic retrograde cholangiopancreatography): A scope is passed into the small intestine and dye is injected into the bile and pancreatic ducts so they show up on X‑ray; this can help diagnose blockages and place stents to relieve jaundice.

Biopsy: confirming the diagnosis

Pancreatic cancer is definitively diagnosed by examining tissue under a microscope.

  • During EUS, the doctor can pass a fine needle into a suspicious area to take cells or tissue (fine‑needle aspiration/biopsy).
  • In some cases, tissue is taken through the skin using image guidance (CT or ultrasound), or during surgery or laparoscopy (a keyhole operation to look inside the abdomen).

Newer tests and high‑risk screening

There is ongoing research into earlier and less invasive ways to detect pancreatic cancer, especially in people with strong family histories or genetic syndromes.

  • Experimental approaches include blood‑based biomarker panels and more sensitive imaging protocols, but these are not yet standard screening tests for the general population.
  • Guidelines generally reserve regular screening (often with MRI and EUS) for people at high inherited risk rather than everyone, because pancreatic cancer is still relatively uncommon but the tests are complex and invasive.

Important: Testing strategies are individualized. Anyone with worrisome symptoms or strong family history should talk directly with a doctor or specialist, because only they can decide which tests are appropriate in a specific case.

Information gathered from public forums or data available on the internet and portrayed here.